Content related to Controlling Cell Turnover in the Intestinal Lining

Inflammatory Bowel Disease (IBD) is a debilitating, incurable condition affecting approximately 1.5 million patients in the USA, with annual health care costs of more than $6 billion. The precise

Inflammatory bowel disease, which includes Crohn’s disease and ulcerative colitis, affects more than 1.4 million Americans and is globally becoming more common. Current medication targets the chronic

A new study at Children’s Hospital Los Angeles outlines an important molecular pathway in the intestines that could improve IBD treatments

Mark Frey, PhD, an investigator at The Saban Research Institute of Children’s Hospital Los Angeles, studies how the intestines repair themselves after injury.

Investigators at Children’s Hospital Los Angeles, led by Tracy C. Grikscheit, MD, have mapped the genetic changes resulting from short bowel syndrome (SBS) using a novel zebrafish model and by

A new study from Children’s Hospital Los Angeles found that a specific pathway may be driving tumor growth in Ewing sarcoma.

A clinical trial at Children’s Hospital Los Angeles is the first to study butyrate therapy in Hispanic children with ulcerative colitis.